Search research articles
Contact Us
Filters
Showing results (11-20 of 185) with videos related to
Page
of 19
Sort By:
Investigational New Drugs
|
August 28, 2009
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model
Lena E Friberg, Marie Sandström, Mats O Karlsson
The Journal of Antimicrobial Chemotherapy
|
January 30, 2014
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
Ami F Mohamed, Otto Cars, Lena E Friberg
The Journal of Antimicrobial Chemotherapy
|
October 22, 2024
Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
Amaury O'Jeanson, Elisabet I Nielsen, Lena E Friberg
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model
Elisabet I Nielsen, Otto Cars, Lena E Friberg
International Journal of Antimicrobial Agents
|
June 23, 2020
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
Anders Thorsted, Elisabet I Nielsen, Lena E Friberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2020
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors
Maddalena Centanni, Sreenath M Krishnan, Lena E Friberg
Jac-Antimicrobial Resistance
|
March 12, 2025
A model-based evaluation of the pharmacokinetics-pharmacodynamics (PKPD) of avibactam in combination with ceftazidime
Amaury O'Jeanson, Elisabet I Nielsen, Lena E Friberg
Antimicrobial Agents and Chemotherapy
|
August 3, 2011
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization
Elisabet I Nielsen, Otto Cars, Lena E Friberg
British Journal of Clinical Pharmacology
|
October 19, 2013
Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response
Brendan C Bender, Emilie Schindler, Lena E Friberg
Investigational New Drugs
|
December 15, 2010
A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model
Angelica Linnea Quartino, Lena E Friberg, Mats O Karlsson
Page
of 19
Search research articles
Search
Showing results (11-20 of 185) with videos related to
Sort By:
Page
of 19
Investigational New Drugs
|
August 28, 2009
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model
Lena E Friberg, Marie Sandström, Mats O Karlsson
The Journal of Antimicrobial Chemotherapy
|
January 30, 2014
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
Ami F Mohamed, Otto Cars, Lena E Friberg
The Journal of Antimicrobial Chemotherapy
|
October 22, 2024
Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
Amaury O'Jeanson, Elisabet I Nielsen, Lena E Friberg
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model
Elisabet I Nielsen, Otto Cars, Lena E Friberg
International Journal of Antimicrobial Agents
|
June 23, 2020
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
Anders Thorsted, Elisabet I Nielsen, Lena E Friberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2020
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors
Maddalena Centanni, Sreenath M Krishnan, Lena E Friberg
Jac-Antimicrobial Resistance
|
March 12, 2025
A model-based evaluation of the pharmacokinetics-pharmacodynamics (PKPD) of avibactam in combination with ceftazidime
Amaury O'Jeanson, Elisabet I Nielsen, Lena E Friberg
Antimicrobial Agents and Chemotherapy
|
August 3, 2011
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization
Elisabet I Nielsen, Otto Cars, Lena E Friberg
British Journal of Clinical Pharmacology
|
October 19, 2013
Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response
Brendan C Bender, Emilie Schindler, Lena E Friberg
Investigational New Drugs
|
December 15, 2010
A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model
Angelica Linnea Quartino, Lena E Friberg, Mats O Karlsson
Page
of 19